Healthcare Services

Viral Hepatitis Market Shaped by Advances in Next-Generation Immunoassay Screening

April 28, 2026April 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Viral Hepatitis Market Expected To Scale Between 2026 And 2030?

The viral hepatitis market size has shown consistent expansion in recent years. It is projected to grow from $16.77 billion in 2025 to $17.37 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 3.6%. This historical growth can be primarily attributed to improvements in blood screening practices, the expansion of vaccination coverage, the availability of antiviral medications, increased disease awareness, and the establishment of public health hepatitis programs.

The viral hepatitis market is projected to experience consistent expansion over the upcoming years. Its valuation is anticipated to reach $20.85 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.7%. This growth during the prediction period is attributable to several factors, including a heightened emphasis on hepatitis eradication efforts, increased funding for new antiviral medications, the broadening scope of point-of-care diagnostic tools, the wider uptake of combination treatments, and the expansion of worldwide screening initiatives. Key trends expected within the same forecast timeframe involve the greater integration of sophisticated antiviral treatments, an increase in the application of molecular diagnostic methods, a stronger emphasis on identifying diseases early, the proliferation of vaccination schemes, and improved surveillance of long-term hepatitis conditions.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13028&type=smp

Which Major Drivers Are Influencing The Expansion Of The Viral Hepatitis Market?

The increasing incidence of hepatitis is projected to drive expansion within the viral hepatitis market in the future. This condition involves an infection of the liver, originating from various infectious viruses and non-infectious agents, potentially leading to diverse health problems. Viral hepatitis, characterized by liver inflammation and damage, can be triggered by viruses such as Hepatitis A, B, C, D, and E. As an illustration, the European Centre for Disease Prevention and Control (ECDC), an EU health agency based in Sweden, indicated in April 2025 that 30 EU/EEA Member States recorded 37,766 new diagnoses of hepatitis B virus (HBV) infection in 2023, representing a crude rate of 8.1 cases per 100 000 population. Consequently, the growing occurrence of hepatitis is anticipated to fuel the viral hepatitis market.

How Is The Viral Hepatitis Market Categorized Across Its Segment Groups?

The viral hepatitis market covered in this report is segmented –

1) By Disease Type: Hepatitis A, Hepatitis B, Hepatitis C, Other Disease Types

2) By Diagnosis: Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis

3) By Treatment: Antiviral Drugs, Surgery, Vaccine, Immune Modulator Drugs, Other Treatments

4) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Hepatitis A: Acute Hepatitis A, Chronic Hepatitis A

2) By Hepatitis B: Acute Hepatitis B, Chronic Hepatitis B, Hepatitis B Carrier

3) By Hepatitis C: Acute Hepatitis C, Chronic Hepatitis C

4) By Other Disease Types: Hepatitis D, Hepatitis E

Which Trends Are Shaping The Viral Hepatitis Market?

Major companies operating in the viral hepatitis market are increasingly focusing on integrating advanced immunoassay technologies, such as automated, dual-marker immunoassays, to enhance early disease detection and monitoring. These automated, dual-marker immunoassays are in-vitro diagnostic tests designed to simultaneously detect both antigen and antibody from a single sample. This capability allows for near-real-time analysis of infection status, a shortened diagnostic window, and improved screening throughput. For instance, in July 2023, Roche Diagnostics India, an India-based provider of in-vitro diagnostics and laboratory automation solutions, introduced Elecsys HCV Duo. This product is a dual-antigen and antibody immunoassay crafted to identify the hepatitis C virus, providing simultaneous independent detection of HCV core antigen and anti-HCV antibodies from a single serum or plasma sample. It enables a significantly earlier diagnosis of active HCV infection and is compatible with automated analyzer platforms such as cobas e 402 and e 801. Elecsys HCV Duo contributes to improved early detection, faster access to care, streamlined diagnostic workflows, and a reduced burden on healthcare systems.

Which Firms Are Influencing Competition In The Viral Hepatitis Market?

Major companies operating in the viral hepatitis market are Pfizer Inc., Johnson & Johnson Co, F Hoffmann-La Roche AG, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy’s Laboratories, Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd., Wockhardt Ltd.

Get The Full Viral Hepatitis Market Report:

https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

Which Region Holds The Highest Market Share In The Viral Hepatitis Market?

North America was the largest region in the viral hepatitis market in 2025. The regions covered in the viral hepatitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Viral Hepatitis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

Browse Through More Reports Similar to the Global Viral Hepatitis Market 2026, By The Business Research Company

Hepatitis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/hepatitis-drugs-global-market-report

Hepatitis Therapeutics Market Report

https://www.thebusinessresearchcompany.com/report/hepatitis-therapeutics-global-market-report

Hepatitis C Market Report

https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795